Stock Events

Stock Events

EvoNext SA 

$2.45
12
+$0.30+13.95% Wednesday 18:22

Statistics

Day High
1.1
Day Low
1.1
52W High
2.45
52W Low
0.9
Volume
20
Avg. Volume
6
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

26AugExpected
Q2 2023
Q4 2023
Q3 2024
Q4 2024
Q2 2025
Q4 2025
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-823,394.39Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ELVAF. It's not an investment recommendation.
UBS Group
2
UBSG.SW

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
BNY Mellon Strategic Municipal Bond Fund
DSM
Mkt Cap288.17M
DSM is a global science-based company active in health, nutrition, and materials, competing with Evolva in the nutrition and health markets.
International Flavors & Fragrances
IFF
Mkt Cap22.44B
International Flavors & Fragrances competes with Evolva in the creation of flavors, fragrances, and cosmetic actives.
Symrise
SYIEY
Mkt Cap14.21B
Symrise AG competes in the flavors and fragrances market, offering products that overlap with Evolva's portfolio.
Archer Daniels Midland
ADM
Mkt Cap39.3B
Archer Daniels Midland Company is a global leader in nutrition and agricultural origination and processing, competing with Evolva in the nutrition sector.
Campbells Co)
CPB
Mkt Cap6.98B
Campbell Soup Company, through its health and wellness initiatives, competes in the food industry segment where Evolva is also active.
Natural Grocers by Vitamin Cottage
NGVC
Mkt Cap633.3M
Natural Grocers by Vitamin Cottage offers natural and organic products, competing with Evolva in the health and wellness retail market.
Kraft Heinz
KHC
Mkt Cap30.48B
The Kraft Heinz Company competes with Evolva in the food and beverage sector, particularly in areas where Evolva offers natural and health-oriented ingredients.

About

EvoNext Holdings SA focuses on the discovery, refinement, and market introduction of innovative components for nutritional, healthcare, and general wellness applications. This enterprise was established in 2004 by Alexandra Santana Sørensen, Søren V. S. Nielsen, and Neil Goldsmith, and maintains its primary base of operations in Reinach, Switzerland.
Show more...
CEO
Gerhard Lobmaier
Employees
49
Country
Switzerland
ISIN
CH1262055788
WKN
000A3D7AP

Listings

MU
DE
ADF0.MU
STU
DE
ADF0.STU
LSE
GB
0QQJ.LSE
F
DE
ADF0.F

0 Comments

Share your thoughts

FAQ

What is EvoNext SA stock price today?▼
The current price of ELVAF is $2.45 USD — it has increased by +13.95% in the past 24 hours. Watch EvoNext SA stock price performance more closely on the chart.
What is EvoNext SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange EvoNext SA stocks are traded under the ticker ELVAF.
Is EvoNext SA stock price growing?▼
ELVAF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year EvoNext SA has showed a +138.89% increase.
What is EvoNext SA revenue for the last year?▼
EvoNext SA revenue for the last year amounts to 0 USD.
What is EvoNext SA net income for the last year?▼
ELVAF net income for the last year is -823,394.39 USD.
How many employees does EvoNext SA have?▼
As of September 02, 2026, the company has 49 employees.
In which sector is EvoNext SA located?▼
EvoNext SA operates in the Health & Wellness sector.
When did EvoNext SA complete a stock split?▼
The last stock split for EvoNext SA was on April 26, 2023 with a ratio of 1:250.
Where is EvoNext SA headquartered?▼
EvoNext SA is headquartered in Reinach, Switzerland.